← All companies

CPMV

Mosaic ImmunoEngineering, Inc.

CPMV OTC Biological Products, (No Diagnostic Substances) EDGAR ↗

$0.48

+0.42 +785.19%

Key statistics

from XBRL data in SEC filings

Market cap

$3.46M

Revenue (TTM)

—

Net income (TTM)

-$682K

EPS (TTM)

$-0.09

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$72.0

Total assets

$9.83K

Gross margin

—

52-week range

$0.05 – $1.05

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-03-31 May 20, 2026 10-K Fiscal year ended 2025-12-31 Apr 15, 2026 10-Q Quarter ended 2025-09-30 Nov 19, 2025 10-Q Quarter ended 2025-06-30 Aug 19, 2025 10-Q Quarter ended 2025-03-31 May 20, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Other events Jan 2, 2025 10-Q Quarter ended 2024-09-30 Nov 19, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Director or officer change Jul 25, 2024 8-K Director or officer change May 31, 2024 8-K Changed accountants May 21, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Regulation FD disclosure; Other events Apr 29, 2024 8-K Director or officer change Apr 19, 2024 10-K Fiscal year ended 2023-12-31 Apr 15, 2024 8-K Entered a material agreement; Terminated a material agreement Mar 28, 2024 10-Q Quarter ended 2023-09-30 Nov 2, 2023 10-Q Quarter ended 2023-06-30 Aug 3, 2023 8-K Entered a material agreement; Other events Jun 26, 2023 10-Q Quarter ended 2023-03-31 May 12, 2023 8-K Director or officer change May 3, 2023 10-K Fiscal year ended 2022-12-31 Mar 2, 2023 10-Q Quarter ended 2022-09-30 Nov 1, 2022 10-Q Quarter ended 2022-06-30 Aug 4, 2022 8-K Entered a material agreement Jul 12, 2022 10-Q Quarter ended 2022-03-31 May 10, 2022 8-K Entered a material agreement; Regulation FD disclosure May 5, 2022 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Modified rights of security holders Feb 22, 2022 10-K Fiscal year ended 2021-12-31 Jan 26, 2022 10-Q Quarter ended 2021-09-30 Nov 2, 2021 10-Q Quarter ended 2021-06-30 Aug 3, 2021 8-K Director or officer change; Shareholder vote results; Other events Jun 15, 2021 8-K Entered a material agreement; Unregistered sale of equity May 10, 2021 10-Q Quarter ended 2021-03-31 May 5, 2021 8-K Amended charter or bylaws Dec 30, 2020 10-Q Quarter ended 2020-11-30 Dec 29, 2020 8-K Modified rights of security holders; Amended charter or bylaws; Other events Dec 1, 2020 8-K/A Director or officer change Nov 19, 2020 10-Q Quarter ended 2020-08-31 Oct 15, 2020